The rich diversity of organic compounds is a result of the remarkable ability of carbon atoms to connect and form bonds with different molecules. Variations in these bonding arrangements, as well as the types of atoms and functional groups involved, result in the formation of isomers. They are a type of compounds that share the same molecular formula but exhibit distinct three-dimensional shapes and properties.
Atropisomers are a type of isomers that are formed when bulky substituents or functional groups get attached to a single bond and experience restricted rotation about the bond. This restriction leads to molecules with a distinct spatial arrangement of atoms and functional groups. Atropisomers are often encountered in compounds containing aromatic rings. Notably, compounds formed as a result of restricted rotation around an N−C single bond between the aromatic ring and the functional group are used as chiral ligands and chiral building blocks to create specific stereoisomers with chiral carbon centers. They often find use in various chemical and pharmaceutical applications. However, maintaining axial chirality around the N−C bond is challenging to attain, and this results in a limited number of synthesizable N−C axially chiral compounds.
In a recent study, researchers have now demonstrated that the Pauson–Khand reaction—a chemical reaction for synthesizing molecules containing cyclopentenones—when applied to atropisomeric substrates, can produce new derivatives containing a chiral carbon. The study was made available online on 2 October 2023 and published in the journal Organic Letters on 13 October 2023. It was led by Professor Osamu Kitagawa from the Department of Applied Chemistry at Shibaura Institute of Technology, Japan along with graduate students Ryohei Kasahara and Tatsuya Toyoda. Possibly the first demonstration of this kind, this breakthrough significantly expands the scope of synthesizing such compounds.
“Although Pauson–Khand reaction is a widely used reaction for the synthesis of many organic compounds, the reaction with atropisomeric substrates had not been explored yet. Out of academic curiosity, we decided to explore the Pauson–Khand reaction with atropisomeric substrates,” says Prof. Kitagawa, while talking about the study.
To this end, the researchers applied an intramolecular version of the reaction to enantioenriched atropisomeric sulfonamides for synthesizing chiral nitrogen-containing tricyclic compounds. They observed that conducting Pauson–Khand reactions on enantioenriched atropisomeric sulfonamides (78–89% ee) containing various substituents in the presence of a Co2(CO)8 complex led to the formation of products with enantiomeric excesses ranging from 78% to 89%. These findings suggest that the Pauson–Khand reaction can effectively transfer chirality from the starting materials to the reaction products with a high degree of selectivity.
“The reaction with enantioenriched N–C axially chiral sulfonamide derivatives proceeded with complete chirality transfer from axial chirality (P configuration) to central chirality (R configuration), affording chiral nitrogen-containing tricyclic compounds,” explains Prof. Kitagawa.
Further, a wide range of substrates were compatible with the reaction, including sulfonamides with methyl-, chloro-, and bromo- substituents, as well as aromatic groups. A crucial factor for the success of this approach was the presence of the Co2(CO)8 complex, which forms an intermediate with the substrate. The specific arrangement of carbon and cobalt atoms within this intermediate controls how alkenes attach to it, promoting the formation of specific enantiomers.
In summary, this level of control over chirality is of significant importance in chemical synthesis and has practical applications in various fields, particularly for the synthesis of pharmaceutical compounds. “With the reaction products possessing a nitrogen-containing tricyclic structure, the reaction can be used for novel applications, such as for the synthesis of natural products and bioactive compounds,” concludes Prof. Kitagawa.
***
Reference
DOI: https://doi.org/10.1021/acs.orglett.3c02893
About Shibaura Institute of Technology (SIT), Japan
Shibaura Institute of Technology (SIT) is a private university with campuses in Tokyo and Saitama. Since the establishment of its predecessor, Tokyo Higher School of Industry and Commerce, in 1927, it has maintained “learning through practice” as its philosophy in the education of engineers. SIT was the only private science and engineering university selected for the Top Global University Project sponsored by the Ministry of Education, Culture, Sports, Science and Technology and will receive support from the ministry for 10 years starting from the 2014 academic year. Its motto, “Nurturing engineers who learn from society and contribute to society,” reflects its mission of fostering scientists and engineers who can contribute to the sustainable growth of the world by exposing their over 8,000 students to culturally diverse environments, where they learn to cope, collaborate, and relate with fellow students from around the world.
Website: https://www.shibaura-it.ac.jp/en/
About Professor Osamu Kitagawa from SIT, Japan
Dr. Osamu Kitagawa is a Professor at the Shibaura Institute of Technology in Japan. He received his BS and PhD from the Tokyo University of Pharmacy and Life Science (then called the Tokyo College of Pharmacy) in 1984 and 1989, respectively. Dr. Kitagawa was working as an Assistant, Lecturer, and Associate Professor there before moving to Shibaura Institute of Technology in 2008. His research interests include the chemistry of novel stereoisomeric molecules and development of novel synthetic organic reactions. He has authored around 100 research articles, which have received more than 4,100 citations.
Journal
Organic Letters
DOI
10.1021/acs.orglett.3c02893
Method of Research
Experimental study
Subject of Research
Not applicable
Article Title
Chirality Transfer Intramolecular Pauson−Khand Reaction with N−C Axially Chiral Sulfonamides Bearing an Ene−Yne Structure
Article Publication Date
13-Oct-2023
COI Statement
The authors declare no competing financial interest.
